Physician profile
Raymond Lee
NPI 1407858749
$11,382.16
in general payments reported to CMS, 2019-2025
24 companies · $1,116 in 2025
The $1,116 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,329 · 2020: $1,136 · 2021: $2,653 · 2022: $2,409 · 2023: $1,257 · 2024: $483 · 2025: $1,116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,603 · Travel and Lodging: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,602.83 |
| Travel and Lodging | $253.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $4,991.73 | 2019-2025 | Impella |
| Abbott Laboratories | $3,845.13 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console |
| Edwards Lifesciences Corporation | $915.52 | 2019-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $646.82 | 2021-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Artivion, INC. | $256.20 | 2019-2024 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Cardiac Non-Synergraft, Bioglue Surgical Adhesive |
| Medtronic, INC. | $190.11 | 2021-2022 | |
| Gilead Sciences, INC. | $88.17 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.02 | 2023 | Xifaxan, Plenvu |
| Kyowa Kirin, INC. | $41.48 | 2019 | |
| Depuy Synthes Sales INC. | $37.94 | 2020 | |
| La Jolla Pharmaceutical Company | $28.76 | 2022 | |
| Getinge USA Sales, LLC | $27.99 | 2024 | Cardiosave Hybrid, Type B Plug |
| Takeda Pharmaceuticals U.S.A., INC. | $27.14 | 2023 | Livtencity |
| Lilly USA, LLC | $25.09 | 2025 | |
| Stryker Corporation | $23.80 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $22.47 | 2019 | |
| Jazz Pharmaceuticals INC. | $21.40 | 2019 | |
| Silk Road Medical, INC. | $20.23 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $18.21 | 2024 | Imfinzi |
| Kci USA, INC. | $17.09 | 2023 | V.A.C.Ulta, Prevena |
| Lemaitre Vascular, INC. | $16.09 | 2023 | Artegraft Vascular Graft |
| Medtronic Vascular, INC. | $15.80 | 2020 | |
| Angiodynamics, INC. | $15.19 | 2022 | |
| Ethicon US, LLC | $13.78 | 2023 | Echelon Flex, Vistaseal, Evarrest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.